Company

UNIVEC, Inc.

Headquarters: Baltimore, MD, United States

CEO: Dr. David Dalton

OTC: UNVC +4.08%

Market Cap

$906,050

USD as of Jan. 1, 2024

Market Cap History

UNIVEC, Inc. market capitalization over time

Evolution of UNIVEC, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of UNIVEC, Inc.

Detailed Description

Univec, Inc., through its subsidiaries, produces, licenses, and markets medical products in the United States and internationally. It primarily provides auto-disable and safety syringes. The company offers 1 cc AD-syringe for aspirating and non-aspirating applications, which are used for dispensing dosages of allergy, immunization, and insulin medicines. It also manufactures and markets sliding sheath syringes that are designed to protect patients and healthcare workers from needle stick injuries; and bifurcated needle safety syringes, which are used in administering smallpox vaccines in response to bio-terrorist threats. Univec markets its auto-disable syringes and sliding sheath safety syringes to private hospitals, health facilities, and distributors in the United States, as well as to governments of developing countries. In addition, it assists pharmaceutical companies in marketing, fulfillment, and tracking drug samples via an online system connecting pharmacies and managed payment providers. The company was founded in 1992 and is based in Baltimore, Maryland.

Top 1-year algo backtest: +284.14%

$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

UNIVEC, Inc. has the following listings and related stock indices.


Stock: OTC: UNVC wb_incandescent

Details

Headquarters:

822 Guilford Avenue

Suite 208

Baltimore, MD 21202

United States

Phone: 410-347-9959

Fax: 410-347-1542